Chemical Structure (Vfend 01)
Vfend Injection, Powder, Lyophilized, For Solution
Product Images NDC 0049-4190
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vfend (NDC 0049-4190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Roerig, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Logo (Vfend 02)
Logo (Vfend 03)
Principal Display Panel (200 mg Vial Label)
This text provides instructions and information about a drug called Voriconazole, which is stored at a controlled room temperature. The drug requires reconstitution with 19 mL of water for injection to give a clear solution containing 10 mg/mL. Each milliliter of the solution includes 10 mg of voriconazole and 160 mg of sulfobutyl ether B-cyclodextrin sodium. The text also suggests that the drug must be diluted before use, and appropriate dosage and usage instructions should be referred to the prescribing physician. The manufacturer of Voriconazole is "Premier Healthcare LOT/EXP Allance, LP," and the drug is made in Ireland.*
Principal Display Panel (200 mg Vial Carton)
Vfend (voriconazole) is an injection used for intravenous infusion after dilution, containing 200mg of voriconazole. It comes in a sterile single-dose vial, and the unused portion must be discarded. The injection should be further diluted before use according to recommended compatible fusion solutions to provide a final solution containing 0.55mg/mL of Vfend. It needs to be stored at controlled room temperature (15-30°C). For appropriate directives and storage recommendations, refer to prescribing information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
